New Delhi: In a big move, Bharat Biotech’s Covaxin has reportedly received approval from Subject Expert Committee (SEC) on COVID-19 for emergency use in children above 2 years in India.
The SEC has submitted recommendations to Drugs Controller General of India (DCGI) for approval of the vaccine for use on children, stated reports.
Once approved, Covaxin will become only second vaccine cleared for use on kids and the only such vaccine for toddlers too. In August, Zydus Cadilla’s three-dose DNA jab was allowed to be used on adults and children over 12.
The Hyderabad-based company had completed Phase-2 and Phase-3 trials of Covaxin on children below 18 years of age in September.
A third potential vaccine for kids is Serum Institute’s Novavax, for which the DCGI last month cleared trials for children between seven and 11 years.
Berhampur: The SUM Hospital at Sitalapalli in Berhampur of Odisha's Ganjam district has successfully performed…
Bhubaneswar: After losing two close games, Odisha posted their first win in the Vijay Hazare…
Bhubaneswar: Odisha Chief Minister Mohan Charan Majhi on Thursday assigned responsibilities of different districts in…
Mumbai: A day before ‘Dabangg’ actor Salman Khan’s birthday, his die-hard fans had a surprise…
New Delhi: Former Prime Minister and veteran Congress leader Dr Manmohan Singh passed away on…
Nabarangpur: An ASI of police reportedly died by suicide by hanging himself from a tree…
This website uses cookies.
